Positive Results for Tirzepatide in Those With the Cardiovascular-Kidney-Metabolic Triad
Tirzepatide produced similar benefits in people with chronic kidney disease as it did in people without and showed signs of...
Tirzepatide produced similar benefits in people with chronic kidney disease as it did in people without and showed signs of...
Coherus BioSciences shared final data from its Phase II trial of casdozokitug, showing a 17.2 percent complete response rate in...
Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk patients...
Chemomab Therapeutics (Nasdaq: CMMB), which is developing treatments for fibro-inflammatory (scarring) diseases, rose 14% on Friday and is up...
Calyxo, Inc., a medical device company developing innovative solutions for patients with kidney stones, has announced positive new study results...
CVAC System (Photo: Business Wire)CVAC System ProcedureMulti-Center ASPIRE 1-Year Study Results Show Healthcare Consumption Events are Significantly Lower after SURE...